Evidence map›Paper›PMID 40320465›Full record

ArticleCerebellum (London, England)2025

The Cerebellar Neuropsychiatric Rating Scale in the Spinocerebellar Ataxias.

Anna L Burt, Maureen P Daly, Janet C Sherman, Jeremy D Schmahmann, CRC-SCA

Abstract read
PubMed Publisher
In one paragraph

Article in Cerebellum (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna L BurtAtaxia Center, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Division of Behavioral Neurology & Integrated Brain Health, Department of Neurology, Mass General Brigham and Harvard Medical School, MGH Ataxia Center, 101 Merrimac Street, Suite 310, Boston, MA, 02114, USA.
Maureen P DalyMesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Janet C ShermanPsychology Assessment Center, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Jeremy D SchmahmannAtaxia Center, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Division of Behavioral Neurology & Integrated Brain Health, Department of Neurology, Mass General Brigham and Harvard Medical School, MGH Ataxia Center, 101 Merrimac Street, Suite 310, Boston, MA, 02114, USA. jschmahmann@mgh.harvard.edu.
CRC-SCA

Funding

Understanding the Cellular Basis of Movement DisordersR01NS082351 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Puneet Opal · 2013 to 2026
$6.2M
Cellular pathways underlying polyglutamine degenerationR01NS062051 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI OPAL, PUNEET · 2010 to 2014
$1.7M
NINDS NIH HHS R01 NS062051NINDS NIH HHS R01 NS082351NINDS NIH HHS R01NS082351-11
6 · The paper itself

Abstract

There is currently no established screening instrument that detects neuropsychiatric features in individuals with cerebellar ataxia. We hypothesized that the Cerebellar Neuropsychiatric Rating Scale (CNRS) would capture the neuropsychiatry of patients enrolled in the natural history study of the Clinical Research Consortium for the Study of Cerebellar Ataxia, and provide novel insights not revealed by other measures. We studied CNRS data in 362 patients with spinocerebellar ataxia types 1, 2, 3, 6, 7, 8, 10, and 27B, and cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS). We grouped patients by mild, moderate, and severe disease severity according to Friedreich Ataxia Rating Scale (FARS) functional stage. We analyzed scores on the CNRS and its five constituent domains for the entire cohort and by severity subgroup. We fit a mixed effects model to examine the effect of severity. We analyzed correlations with other clinical measures: Cerebellar Cognitive Affective / Schmahmann Syndrome Scale (CCAS-S), Patient-Reported Outcome Measure of Ataxia (PROM-Ataxia), Patient Health Questionnaire-9 (PHQ-9), Euro-Qol 5-Dimension (EQ-5D), and Fatigue Severity Scale (FSS). The CNRS detected neuropsychiatric symptoms, with highest scores on Attentional and Emotional Control domains. The mixed effects model revealed that ataxia severity influences scores, with mean scores increasing with ataxia severity. The CNRS correlated with the PROM-Ataxia Mental domain, particularly between Emotional Control and section 1 (psychiatric) items. Emotional Control also correlated with PHQ-9 and EQ-5D. Correlations with the CCAS-S Affect and FSS were weak. The CNRS provides novel neuropsychiatric insights into spinocerebellar ataxia that are missed by other measures.

Indexed as

CerebellumNeuropsychological TestsPsychiatric Status Rating ScalesSpinocerebellar AtaxiasAdultAgedFemaleHumansMaleMiddle AgedSeverity of Illness IndexYoung AdultCerebellar Cognitive Affective/Schmahmann SyndromeCerebellumClinical Outcome AssessmentNeuropsychiatrySocial CognitionSpinocerebellar Ataxia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.